Social Media Ideas for Aacr D3 2026

Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development

During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...

From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance

The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next generation of cancer treatments. We spoke with Andrea Wang-Gil...

AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More

We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference, including investigational KRAS degraders, approaches...

Breaking News: Daraxonrasib Approved for Pancreatic Cancer

Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on...

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on D...

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and...

Editors’ Picks, August 2026: Weight Loss and Breast Cancer Biomarkers, Predicting Early-onset Cancer Cases, and More

The August 2026 Editors’ Picks from AACR journals cover the impact of weight loss and omega-3 supplementation on breast cancer risk, early-onset cancer prediction, and more. The...

 ISRT 2026: Advancing Cancer Care in Africa

The International Symposium on Radiopharmaceutical Therapy (ISRT) 2026 will take place on 28–29 August 2026 at Loveworld Medical Centre, Lagos, Nigeria, bringing together an extens...

Smart Chemotherapy Gets Smarter: Advances in Antibody-drug Conjugates

Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New research has helped to revolutionize the drug class and de...

Editors’ Picks, July 2026: AI-powered Pancreatic Proteomics, Sex-based Immune Differences, and More

In July, the editors from AACR's 10 peer-reviewed journals highlighted research on AI-driven molecular mapping of pancreatic cancer evolution, sex differences in immune responses,...

Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact

Roche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) designed for the growing pool of patients who progress after treatment with...

NADGC 2026

The National Amateur Disc Golf Championship (NADGC) is rapidly approaching, and excitement continues to build as organizers unveil new courses, expanded player packs, and a lineup...

Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough

Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bis...

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved reco...

Delhi Premier League T20 2026: Schedule, Broadcast and Live Streaming details for DPL Season 3

The highly anticipated third edition of the Delhi Premier League (DPL 2026) is all set to get underway on July 31 at the Arun Jaitley Stadium in New Delhi. Organised by the Delhi &...

Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts

The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress

At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cance...

<![CDATA[2026 Emerging Pharma Leaders]]>

Digi Q3 FY2026 slides: record margins, 52% ARR growth

Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innov...

SHANGHAI and HONG KONG, Aug. 23, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedi...

Celcuity plans late Q3 2026 REVTORPYK shipments and targets sNDA submission in Q3 2026

2025: Our sector's footprint

Published: June 2025 This infographic outlines key facts and figures about our members and the research they fund. To facilitate the sharing of these stats, you can view and downl...